A Form 4 filed on August 12, 2026 discloses that Nirav R Shah, a director of STERIS plc (NYSE:STE), acquired Director Stock Options and Career Restricted Stock Units on August 10, 2026.

Key Highlights

  • Reporting person: Nirav R Shah, identified as a Director of STERIS plc.
  • Stock options granted: 1,506 Director Stock Options (right to buy) at an exercise price of $238.91 per share, with an expiration date of 08/10/2036, reported as fully vested and exercisable immediately.
  • Career RSUs granted: 512 Career Restricted Stock Units acquired on 08/10/2026, reported as fully vested immediately, to be settled in STERIS ordinary shares six months after cessation of the Director's Board service.
  • Post-transaction RSU holdings: Following the transaction, Shah beneficially owns 7,015 Career Restricted Stock Units directly.
  • Price of derivative securities: Both the stock options and Career RSUs were acquired at a reported price of $0.
  • Filing signed by: John P. Ubbing, as Authorized Representative under Power of Attorney, on August 12, 2026.

STERIS Director Shah Receives Options and Restricted Stock Units in August 2026

According to the filing, Nirav R Shah, a director of STERIS plc, received two types of equity awards on August 10, 2026. The first award consisted of 1,506 Director Stock Options with an exercise price of $238.91 per ordinary share and an expiration date of August 10, 2036. The filing notes that "these nonqualified stock options are fully vested and are exercisable immediately." The reported price of the derivative security was $0, and Shah directly holds 1,506 of these options following the transaction.

The second award consisted of 512 Career Restricted Stock Units, also acquired on August 10, 2026 at a reported price of $0. The filing states that each Career Restricted Stock Unit "represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service," and that the units "are fully vested immediately." Following this grant, Shah's direct beneficial ownership of Career Restricted Stock Units stands at 7,015, according to the filing.

The Form 4 was filed on August 12, 2026 and covers transactions dated August 10, 2026. No transactions were reported in Table I covering non-derivative securities. The filing was submitted by John P. Ubbing as Authorized Representative under Power of Attorney on Shah's behalf.

What Was Disclosed

The filing discloses the acquisition of 1,506 Director Stock Options at $238.91 and 512 Career Restricted Stock Units by STERIS plc director Nirav R Shah on August 10, 2026, bringing his total direct Career RSU holdings to 7,015.